DIN 02540207 — AREXVY 120 MCG
AREXVY is a powder for suspension of Respiratory syncytial virus prefusion F protein marketed by GLAXOSMITHKLINE INC. The full Respiratory syncytial virus prefusion F protein monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02540207
- Brand name
- AREXVY
- Active ingredient
- Respiratory syncytial virus prefusion F protein
- Strength
- 120 MCG
- Dosage form
- POWDER FOR SUSPENSION
- Route
- INTRAMUSCULAR
- Manufacturer
- GLAXOSMITHKLINE INC
- Health Canada status
- MARKETED
- Drug class
- Recombinant, adjuvanted subunit vaccine (active immunizing agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.